Cargando…
Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
Only a small fraction of early drug programs progress to the market, due to safety and efficacy failures, despite extensive efforts to predict safety. Characterizing the effect of natural variation in the genes encoding drug targets should present a powerful approach to predict side effects arising...
Autores principales: | Nguyen, Phuong A., Born, David A., Deaton, Aimee M., Nioi, Paul, Ward, Lucas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450952/ https://www.ncbi.nlm.nih.gov/pubmed/30952858 http://dx.doi.org/10.1038/s41467-019-09407-3 |
Ejemplares similares
-
Author Correction: Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
por: Nguyen, Phuong A., et al.
Publicado: (2019) -
Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence
por: Deaton, Aimee M, et al.
Publicado: (2019) -
Rare coding variants in DNA damage repair genes associated with timing of natural menopause
por: Ward, Lucas D., et al.
Publicado: (2021) -
Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes
por: Deaton, Aimee M., et al.
Publicado: (2021) -
Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”
por: Ward, Lucas D., et al.
Publicado: (2018)